Finance

Lists
Why is 002100 down 3.07%?
Dive Deeper
002100:SHE
Tecon Biology Co Ltd
CN¥7.57
-3.07%
(-0.24) 1D
Oct 30, 3:04:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002100...
Open
CN¥7.77
High
CN¥7.79
Low
CN¥7.54
Mkt. cap
10.33B
Avg. vol.
23.40M
Volume
20.16M
Dividend
1.03%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 10, 2026
52-wk high
CN¥8.53
52-wk low
CN¥5.64
EPS
-CN¥0.58
Shares outstanding
1.37B
No. of employees
5K
Open
CN¥7.77
High
CN¥7.79
Low
CN¥7.54
Mkt. cap
10.33B
Avg. vol.
23.40M
Volume
20.16M
Dividend
1.03%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 10, 2026
52-wk high
CN¥8.53
52-wk low
CN¥5.64
EPS
-CN¥0.58
Shares outstanding
1.37B
No. of employees
5K
News stories
From web sources and news partners
About Tecon Biology Co Ltd
CEO-
Employees4.8K
Founded1993
Headquarters-
SectorFood
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.37B
3.92B
4.41B
4.49B
Cost of goods sold
3.22B
3.77B
4.45B
4.36B
Cost of revenue
3.22B
3.77B
4.45B
4.36B
Research and development expenses
16.43M
37.21M
38.81M
38.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
233.16M
207.70M
200.93M
224.80M
Operating expense
306.54M
279.19M
267.87M
299.61M
Total operating expenses
3.53B
4.04B
4.71B
4.66B
Operating income
-156.33M
-127.94M
-305.81M
-164.22M
Other non operating income
-85.64M
-3.86M
16.08M
-21.23M
EBT including unusual items
-187.28M
-163.69M
-325.22M
-161.45M
EBT excluding unusual items
-249.97M
-162.79M
-317.57M
-212.76M
Income tax expense
17.27M
8.82M
-3.53M
-3.03M
Effective tax rate
-9.22%
-5.39%
1.09%
1.88%
Other operating expenses
55.85M
14.04M
14.40M
14.51M
Net income
-201.11M
-163.28M
-278.19M
-154.56M
Net profit margin
-5.97%
-4.17%
-6.31%
-3.44%
Earnings per share
-
-
-
-
Interest and investment income
39.20M
4.21M
3.16M
8.89M
Interest expense
-47.15M
-35.20M
-31.01M
-36.21M
Net interest expenses
-7.96M
-30.99M
-27.85M
-27.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.04M
35.43M
179.96M
-848.41K
Gain or loss from assets sale
-587.07K
-
-299.95K
299.95K
Upcoming events
AI content may include mistakes. Learn more
Google apps